BlackRock, Inc. 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Altimmune, Inc. ALT |
BLACKROCK INC BLK |
6,159,305 8.700% |
2,114,598 (+52.28%) |
Filing |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Altimmune, Inc. ALT |
BLACKROCK INC BLK |
4,044,707 7.500% |
3,082,523 (+320.37%) |
Filing |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Altimmune, Inc. ALT |
BLACKROCK INC BLK |
962,184 2.200% |
-1,994,083 (-67.45%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Altimmune, Inc. ALT |
BLACKROCK INC BLK |
2,956,267 7.400% |
2,956,267 (New Position) |
Filing |